AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2015
Jun 18, 2015
35086_dirs_2015-06-18_a50d07f6-0eb3-46b4-9046-0321a3091be5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2015-06-17
Reporting Person: Laghrissi-Thode Fouzia (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-17 | Stock Option (right to buy) | $ | A | 25000 | Acquired | 2025-06-17 | Common Stock (25000) | Direct |
Footnotes
F1: The exercise price shall be the closing price of the Issuer's Common Stock on July 1, 2015.
F2: The shares shall vest quarterly over 3 years beginning on May 18, 2015.
More from Minerva Neurosciences, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17